Regulations
thumbnail
RegulationsPfizer wins approval for $3.5m hemophilia B gene therapyPfizer wins approval for $3.5m hemophilia B gene therapy
The US FDA has approved Beqvez (fidanacogene elaparvovec), Pfizer’s adeno-associated virus (AAV) based gene therapy for the treatment of hemophilia B.